anti-HIV2 p26 antibody product blog
Tags: Antibody; Monoclonal Antibody; HIV2 p26; anti-HIV2 p26 antibody;
The HIV2 p26 n/a (Catalog #MBS838291) is an Antibody produced from Mouse and is intended for research purposes only. The product is available for immediate purchase. The HIV2 p26 antibody reacts with Binds to recombinant p26 (HIV-2 ROD) in ELISA and Western Blot. Antibody is not epitope mapped. and may cross-react with other species as described in the data sheet. MyBioSource\'s HIV2 p26 can be used in a range of immunoassay formats including, but not limited to, ELISA (EIA), Western Blot (WB).If antibody concentration is 1 mg/ml, suggested starting dilutions: ELISA: 1:1,000
WB: 1:500-1:1,000
Optimal dilutions to be determined by the end user. Researchers should empirically determine the suitability of the HIV2 p26 n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Mouse monoclonal HIV2 gp26 antibody.
Biological Significance: HIV2 infections at present, are predominantly found in west Africa where it is the dominant form of HIV. In persons infected with HIV2, immunodeficiency seems to develop more slowly and to be milder, but as the disease advances, HIV2 infectiousness seems to increase. Immunogen: Purified, full �length recombinant p26 (HIV-2 ROD) produced in E Coli Expression system
Dry Ice Shipment: Extra charge fee may add to your shipping cost as dry ice is required to ship this product. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing HIV2 p26 are readily searchable from our website. Different antibodies against the same target such as HIV2 p26 may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.